CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to fight cancer without harming the heart
Disease control Recruiting nowThis study is testing a cancer drug called acalabrutinib for patients with chronic lymphocytic leukemia (CLL). It focuses on patients who had to stop a similar drug, ibrutinib, because of heart-related side effects. The main goal is to see if switching to acalabrutinib can effect…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Seema Bhat • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug combo trial offers hope for blood cancer patients
Disease control Recruiting nowThis study is testing whether adding the experimental drug DZD8586 to treatment helps control chronic lymphocytic leukemia or small lymphocytic lymphoma. Researchers will enroll 66 adults with newly diagnosed or untreated forms of these blood cancers. The trial has two parts: fir…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Dizal (Jiangsu) Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
New drug trial offers hope for Tough-to-Treat blood cancers
Disease control Recruiting nowThis study is testing whether an experimental drug called DZD8586 works better than standard treatments at controlling cancer growth in adults with chronic lymphocytic leukemia or small lymphocytic lymphoma that has returned or stopped responding to prior therapy. About 250 parti…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Dizal (Jiangsu) Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New pill tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing an experimental pill called DZD8586 for adults whose chronic lymphocytic leukemia or small lymphocytic lymphoma has come back or stopped responding to prior treatments. Researchers want to see if the drug can shrink tumors and understand what side effects pa…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Can a workout boost your Body's defenses against cancer?
Knowledge-focused Recruiting nowThis study aims to understand how exercise affects the immune systems of people with slow-growing blood cancers like chronic lymphocytic leukemia (CLL) and indolent non-Hodgkin lymphoma. Researchers will measure immune cell activity in about 70 participants before and after a sin…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Hidden heart risks: tiny monitors track cancer drug side effects
Knowledge-focused Recruiting nowThis study aims to understand how often irregular heartbeats occur in cancer patients starting BTK inhibitor medications. Researchers will implant small heart monitors in 50 patients to continuously track their heart rhythms for up to five years. The goal is to see how frequently…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: NA • Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:54 UTC